Plantronics Announces First Quarter Fiscal Year 2017

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Plantronics Announces First Quarter Fiscal Year 2017 Financial Results

SANTA CRUZ, CA --(Marketwired - August 02, 2016) - Plantronics, Inc. ( NYSE : PLT ) today announced first quarter fiscal year 2017 financial results. Highlights of the first quarter include the following (comparisons are against the first quarter of fiscal year 2016):

  • Net revenues were $223.1 million, an increase of 8% compared with $206.4 million, and above our guidance range of $207 million to $217 million
  • GAAP gross margin was 50.7% compared with 52.0%
    • Non-GAAP gross margin was 51.1% compared with 52.4%
  • GAAP operating income was $31.3 million compared with $29.4 million
    • Non-GAAP operating income was $38.7 million compared with $37.5 million
  • GAAP diluted earnings per share ("EPS") was $0.62 compared with $0.55, and above our guidance range of $0.45 to $0.55
    • Non-GAAP diluted EPS was $0.76 compared with $0.67, and above our guidance range of $0.63 to $0.73

To view the image associated with this press release, click on the following link: http://www.marketwire.com/library/MwGo/2016/8...a0e8e1.jpg

"Our upside to expectations was driven by record results in Unified Communications and our strongest ever non-holiday quarter in Consumer Stereo Bluetooth products. In addition, our award winning mono Bluetooth product, the Voyager 5200, strengthened our position, resulting in year over year revenue growth and further share gains," stated Ken Kannappan, President & CEO. "We are targeting an improved Non-GAAP operating margin in fiscal year 2017 compared with the prior year."

"Our operating expenses grew at a lower rate than revenues, resulting in operating profit growth of 3.2% and EPS growth of 13%, despite a one-time $5 million charge related to the GN litigation," stated Pam Strayer, Senior Vice President and Chief Financial Officer. "We continue to focus on building a scalable organization and developing new revenue opportunities, while managing our expenses for operating margin expansion in fiscal 2017."

Enterprise net revenues grew by 3% to $155.9 million in the first quarter of fiscal year 2017 compared with $151.8 million in the first quarter of fiscal year 2016.

Consumer net revenues grew by 23% to $67.2 million in the first quarter of fiscal year 2017, up from $54.6 million in the first quarter of fiscal year 2016.

GN Litigation Charge & Expenses

We announced a one-time charge related to GN Netcom of $5.0 million, which was included in Non-GAAP results, in addition to higher than typical litigation costs related to the case of $2.2 million. Despite the materially unfavorable charge and higher than expected litigation costs included in Non-GAAP results, we exceeded previously provided guidance.

Plantronics Announces Quarterly Dividend of $0.15

We are also announcing that we have declared a quarterly dividend of $0.15 per common share, to be paid on September 9, 2016 to all shareholders of record as of the close of business on August 19, 2016.

New 1,000,000 Share Repurchase Program

We are announcing a new 1,000,000 share repurchase program to commence after repurchasing the approximately 90,000 shares remaining under the existing 1,000,000 share repurchase program.

Business Outlook

The following statements are based on our current expectations and many of these statements are forward-looking. Actual results are subject to a variety of risks and uncertainties and may differ materially from our expectations.

We have a "book and ship" business model whereby we fulfill the majority of orders received within 48 hours of receipt of those orders. However, our backlog is occasionally subject to cancellation or rescheduling by our customers on short notice with little or no penalty. Therefore, there is a lack of meaningful correlation between backlog at the end of a fiscal period and net revenues in a succeeding fiscal period.

Our business is inherently difficult to forecast, particularly with continuing uncertainty in regional economic conditions and currency fluctuations, and there can be no assurance that expectations of incoming orders over the balance of the current quarter will materialize.

Subject to the foregoing, we currently expect the following range of financial results for the second quarter of fiscal year 2017 (all amounts assuming currency rates remain stable):

  • Net revenues of $215 million to $225 million;
  • GAAP operating income of $29 million to $34 million;
  • Non-GAAP operating income of $39 million to $44 million, excluding the impact of $8 million from stock-based compensation; and executive severance charges of $2 million
  • Assuming approximately 33 million diluted average weighted shares outstanding:
    • GAAP diluted EPS of $0.51 to $0.61;
    • Non-GAAP diluted EPS of $0.73 to $0.83; and
  • Cost of stock-based compensation to be approximately $0.16 per diluted share and the cost of executive severance to be approximately $0.06 per diluted share

Please see our updated Investor Relations Presentation available on our corporate website at www.plantronics.com/ir .

Conference Call and Prepared Remarks

Plantronics is providing a copy of prepared remarks in combination with its press release. These remarks are offered to provide shareholders and analysts with additional time and detail for analyzing results in advance of our quarterly conference call. The remarks will be available in the Investor Relations section of our website in conjunction with the press release.

We have scheduled a conference call to discuss first quarter fiscal year 2017 financial results. The conference call will take place today, August 2, 2016 at 2:00 PM (Pacific Time). All interested investors and potential investors in our stock are invited to participate. To listen to the call, please dial in five to ten minutes prior to the scheduled starting time and refer to the "Plantronics Conference Call." The dial-in from North America is (888) 301-8736 and the international dial-in is (706) 634-7260.

A replay of the call with the conference ID #44577748 will be available until September 3, 2016 at (855) 859-2056 or (800) 585-8367 for callers from North America and at (404) 537-3406 for all other callers. The conference call will also be simultaneously webcast in the Investor Relations section of our corporate website at www.plantronics.com/ir , and the webcast of the conference call will remain available on our website for one month. A reconciliation between our GAAP and non-GAAP results is provided in the tables at the end of this press release.

Use of Non-GAAP Financial Information

To supplement our condensed consolidated financial statements presented on a GAAP basis, we use non-GAAP measures of operating results, including non-GAAP operating income, non-GAAP net income and non-GAAP diluted EPS which exclude certain non-cash expenses and charges that are included in the most directly comparable GAAP measure. These non-cash charges and expenses include stock-based compensation related to stock options, restricted stock and employee stock purchases made under our employee stock purchase plan, purchase accounting amortization, accelerated depreciation, and early lease termination charges, all net of the associated tax impact, tax benefits from the release of tax reserves, transfer pricing, tax deduction and tax credit adjustments, and the impact of tax law changes. We exclude these expenses from our non-GAAP measures primarily because management does not believe they are part of our target operating model. We believe that the use of non-GAAP financial measures provides meaningful supplemental information regarding our performance and liquidity and helps investors compare actual results with our long-term target operating model goals. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods; however, non-GAAP financial measures are not meant to be considered in isolation or as a substitute for, or superior to, gross margin, operating income, operating margin, net income or EPS prepared in accordance with GAAP.

As a company with significant global operations and sales, fluctuations in foreign currency exchange rates may have a material effect on our reported results. Consequently, we also present supplemental metrics as identified in the reconciliation within this release "on a constant currency basis" which excludes the impact of currency exchange rate fluctuations. The constant currency presentation, which is a non-GAAP measure, is intended to supplement our reported operating results and, when considered in conjunction with the corresponding GAAP measures, facilitate a better understanding of changes in the metrics from period to period and core operations. We calculate constant currency percentages by removing any hedge gains or losses from the particular metric in the current period and then converting our current period local currency financial results using the foreign currency exchange rates in effect during the prior year period and comparing these adjusted amounts to the corresponding current period metric.

Safe Harbor

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to: (i) improving Non-GAAP operating margin in fiscal year 2017 as compared to fiscal year 2016; (ii) our intention to focus on scaling the organization and developing new revenue opportunities while managing expenses to expand operation margin in fiscal year 2017; (iii) estimates of GAAP and non-GAAP financial results for the second quarter of fiscal year 2017, including net revenues, operating income and diluted EPS; (iv) our estimates of stock-based compensation and purchase accounting amortization and other related charges, as well as the impact of these non-cash expenses on Non-GAAP operating income and diluted EPS for the second quarter of fiscal year 2017; and (v) our estimate of weighted average shares outstanding for the second quarter of fiscal year 2017, in addition to other matters discussed in this press release that are not purely historical data. We do not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise.

Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contemplated by such statements. Among the factors that could cause actual results to differ materially from those contemplated are:

  • Micro and macro-economic conditions in our domestic and international markets;
  • our ability to realize and achieve positive financial results projected to arise from UC adoption could be adversely affected by a variety of factors including the following: (i) as UC becomes more widely adopted, the risk that competitors will offer solutions that will effectively commoditize our headsets which, in turn, will reduce the sales prices for our headsets; (ii) our plans are dependent upon adoption of our UC solution by major platform providers and strategic partners such as Microsoft Corporation, Cisco Systems, Inc., Avaya, Inc., and Alcatel-Lucent, and our influence over such providers with respect to the functionality of their platforms or their product offerings, their rate of deployment, and their willingness to integrate their platforms and product offerings with our solutions is limited; (iii) delays or limitations on our ability to timely introduce solutions that are cost effective, feature-rich, stable, and attractive to our customers within forecasted development budgets; (iv) our successful implementation and execution of new and different processes involving the design, development, and manufacturing of complex electronic systems composed of hardware, firmware, and software that works seamlessly and continuously in a wide variety of environments and with multiple devices; (v) our sales model and expertise must successfully evolve to support complex integration of hardware and software with UC infrastructure consistent with changing customer purchasing expectations; (vi) as UC becomes more widely adopted we anticipate that competition for market share will increase, particularly given that some competitors may have superior technical and economic resources; (vii) UC solutions generally, or our solutions in particular, may not be adopted with the breadth and speed in the marketplace that we currently anticipate; (viii) sales cycles for more complex UC deployments are longer as compared to our traditional Enterprise products; (ix) UC may evolve rapidly and unpredictably and our inability to timely and cost-effectively adapt to those changes and future requirements may impact our profitability in this market and our overall margins; and (x) our failure to expand our technical support capabilities to support the complex and proprietary platforms in which our UC products are and will be integrated;
  • failure to match production to demand given long lead times and the difficulty of forecasting unit volumes and acquiring the component parts and materials to meet demand without having excess inventory or incurring cancellation charges;
  • volatility in prices from our suppliers, including our manufacturers located in China, have in the past and could in the future negatively affect our profitability and/or market share;
  • fluctuations in foreign exchange rates;
  • with respect to our stock repurchase program, prevailing stock market conditions generally, and the price of our stock specifically;
  • the bankruptcy or financial weakness of distributors or key customers, or the bankruptcy of or reduction in capacity of our key suppliers;
  • additional risk factors including: interruption in the supply of sole-sourced critical components, continuity of component supply at costs consistent with our plans, and the inherent risks of our substantial foreign operations; and
  • seasonality in one or more of our product categories.

For more information concerning these and other possible risks, please refer to our Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 16, 2016 and other filings with the Securities and Exchange Commission, as well as recent press releases. The Securities and Exchange Commission filings can be accessed over the Internet at http://www.sec.gov/edgar/searchedgar/companysearch.html .

Financial Summaries

The following related charts are provided:

  • Summary Unaudited Condensed Consolidated Financial Statements
  • Unaudited Reconciliations of GAAP Measures to Non-GAAP Measures
  • Summary of Unaudited Reconciliations of GAAP Measures to Non-GAAP Measures and Other Unaudited GAAP Data

About Plantronics

Plantronics is a global leader in audio communications for businesses and consumers. We have pioneered new trends in audio technology for over 50 years, creating innovative products that allow people to simply communicate . From Unified Communication solutions to Bluetooth headsets, we deliver uncompromising quality, an ideal experience, and extraordinary service. Plantronics is used by every company in the Fortune 100, as well as 911 dispatch, air traffic control and the New York Stock Exchange. For more information, please visit www.plantronics.com or call (800) 544-4660.

Plantronics is a registered trademark of Plantronics, Inc. The Bluetooth name and the Bluetooth trademarks are owned by Bluetooth SIG, Inc. and are used by Plantronics, Inc. under license. All other trademarks are the property of their respective owners.

 
PLANTRONICS, INC.
SUMMARY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
($ in thousands, except per share data)
 
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
         
    Three Months Ended
    June 30,
    2015   2016
Net revenues   $ 206,358     $ 223,106  
Cost of revenues     99,000       110,033  
Gross profit     107,358       113,073  
  Gross profit %     52.0 %     50.7 %
                 
Research, development and engineering     23,194       22,344  
Selling, general and administrative     55,678       55,787  
(Gain) loss, net from litigation settlements     (876 )     4,739  
Restructuring and other related charges     -       (1,048 )
  Total operating expenses     77,996       81,822  
    Operating income     29,362       31,251  
    Operating income %     14.2 %     14.0 %
                 
Interest expense     (2,741 )     (7,288 )
Other non-operating income and (expense), net     (285 )     2,352  
Income before income taxes     26,336       26,315  
Income tax expense     5,108       5,928  
    Net income   $ 21,228     $ 20,387  
                 
    % of net revenues     10.3 %     9.1 %
                 
Earnings per common share:                
  Basic   $ 0.56     $ 0.63  
  Diluted   $ 0.55     $ 0.62  
                 
Shares used in computing earnings per common share:                
  Basic     38,002       32,243  
  Diluted     38,943       32,818  
                 
Effective tax rate     19.4 %     22.5 %
 
 
PLANTRONICS, INC.
SUMMARY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
($ in thousands)
 
UNAUDITED CONSOLIDATED BALANCE SHEETS
    March 31,   June 30,
    2016   2016
ASSETS            
  Cash and cash equivalents   $ 235,266   $ 227,473
  Short-term investments     160,051     171,899
    Total cash, cash equivalents and short-term investments     395,317     399,372
  Accounts receivable, net     128,219     133,155
  Inventory, net     53,162     53,912
  Other current assets     20,297     26,151
    Total current assets     596,995     612,590
  Long-term investments     145,623     132,270
  Property, plant and equipment, net     149,735     151,863
  Goodwill and purchased intangibles, net     15,827     15,765
  Other assets     25,257     19,450
    Total assets   $ 933,437   $ 931,938
LIABILITIES AND STOCKHOLDERS' EQUITY            
  Accounts payable   $ 39,133   $ 46,817
  Accrued liabilities     70,034     60,670
    Total current liabilities     109,167     107,487
  Long-term debt, net of issuance costs     489,609     489,971
  Long-term income taxes payable     11,968     12,464
  Other long-term liabilities     10,294     11,448
    Total liabilities     621,038     621,370
  Stockholders' equity     312,399     310,568
    Total liabilities and stockholders' equity   $ 933,437   $ 931,938
             
 
 
PLANTRONICS, INC.
SUMMARY CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
($ in thousands, except per share data)
 
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
         
    Three Months Ended
    June 30,
    2015   2016
Cash flows from operating activities                
  Net Income   $ 21,228     $ 20,387  
  Adjustments to reconcile net income to net cash provided by operating activities:                
    Depreciation and amortization     4,986       5,146  
    Amortization of debt issuance cost     121       362  
    Stock-based compensation     8,050       8,413  
    Excess tax benefit from stock-based compensation     (2,391 )     (339 )
    Deferred income taxes     4,146       4,890  
    Provision for excess and obsolete inventories     402       772  
    Restructuring charges     -       (1,048 )
    Cash payments for restructuring charges     -       (2,788 )
    Other operating activities     4,537       (1,920 )
  Changes in assets and liabilities:                
    Accounts receivable, net     8,579       (4,529 )
    Inventory, net     358       (1,486 )
    Current and other assets     (2,869 )     (672 )
    Accounts payable     4,958       7,055  
    Accrued liabilities     (6,212 )     (1,370 )
    Income taxes     (2,419 )     (2,736 )
      Cash provided by operating activities     43,474       30,137  
                 
Cash flows from investing activities                
  Proceeds from sale of investments     16,375       74,349  
  Proceeds from maturities of investments     25,425       34,353  
  Purchase of investments     (43,834 )     (106,711 )
  Capital expenditures     (3,966 )     (7,579 )
    Cash used for investing activities     (6,000 )     (5,588 )
                 
Cash flows from financing activities                
  Repurchase of common stock     (284,444 )     (18,639 )
  Employees' tax withheld and paid for restricted stock and restricted stock units     (9,903 )     (8,792 )
  Proceeds from issuances under stock-based compensation plans     3,077       733  
  Proceeds from revolving line of credit     155,749       -  
  Repayments of revolving line of credit     (190,249 )     -  
  Proceeds from bonds issuance, net     489,670       -  
  Payment of cash dividends     (5,828 )     (4,970 )
  Excess tax benefit from stock-based compensation     2,391       339  
    Cash provided by (used for) financing activities     160,463       (31,329 )
Effect of exchange rate changes on cash and cash equivalents     592       (1,013 )
    Net increase (decrease) in cash and cash equivalents     198,529       (7,793 )
Cash and cash equivalents at beginning of period     276,850       235,266  
Cash and cash equivalents at end of period   $ 475,379     $ 227,473  
                 
 
 
PLANTRONICS, INC.
UNAUDITED RECONCILIATIONS OF GAAP MEASURES TO NON-GAAP MEASURES
($ in thousands, except per share data)
 
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS DATA
         
    Three Months Ended
    June 30,
    2015   2016
GAAP Gross profit   $ 107,358     $ 113,073  
  Stock-based compensation     779       842  
Non-GAAP Gross profit   $ 108,137     $ 113,915  
Non-GAAP Gross profit %     52.4 %     51.1 %
                 
GAAP Research, development and engineering   $ 23,194     $ 22,344  
  Stock-based compensation     (2,359 )     (2,484 )
  Purchase accounting amortization     (62 )     (62 )
Non-GAAP Research, development and engineering   $ 20,773     $ 19,798  
                 
GAAP Selling, general and administrative   $ 55,678     $ 55,787  
  Stock-based compensation     (4,912 )     (5,087 )
Non-GAAP Selling, general and administrative   $ 50,766     $ 50,700  
                 
GAAP Operating expenses   $ 77,996     $ 81,822  
  Stock-based compensation     (7,271 )     (7,571 )
  Purchase accounting amortization     (62 )     (62 )
  Restructuring and other related charges     -       1,048  
Non-GAAP Operating expenses   $ 70,663     $ 75,237  
                 
 
 
PLANTRONICS, INC.
UNAUDITED RECONCILIATIONS OF GAAP MEASURES TO NON-GAAP MEASURES
($ in thousands, except per share data)
 
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS DATA (CONTINUED)
                 
    Three Months Ended    
    June 30,    
    2015       2016    
GAAP Operating income   $ 29,362       $ 31,251    
  Stock-based compensation     8,050         8,413    
  Purchase accounting amortization     62         62    
  Restructuring and other related charges     -         (1,048 )  
Non-GAAP Operating income   $ 37,474       $ 38,678    
                     
GAAP Net income   $ 21,228       $ 20,387    
  Stock-based compensation     8,050         8,413    
  Purchase accounting amortization     62         62    
  Restructuring and other related charges     -         (1,048 )  
  Income tax effect of above items     (2,338 )       (2,753 )  
  Income tax effect of unusual tax items     (994 ) (1)     (86 ) (1)
Non-GAAP Net income   $ 26,008       $ 24,975    
                     
GAAP Diluted earnings per common share   $ 0.55       $ 0.62    
  Stock-based compensation     0.21         0.26    
  Restructuring and other related charges     -         (0.03 )  
  Income tax effect     (0.09 )       (0.09 )  
Non-GAAP Diluted earnings per common share   $ 0.67       $ 0.76    
                     
Shares used in diluted earnings per common share calculation     38,943         32,818    
                     
(1) Excluded amounts represent tax benefits from the release of tax reserves.

Use of Non-GAAP Financial Information

To supplement our condensed consolidated financial statements presented on a GAAP basis, we use non-GAAP measures of operating results, including non-GAAP operating income, non-GAAP net income and non-GAAP diluted EPS which exclude certain non-cash expenses and charges that are included in the most directly comparable GAAP measure. These non-cash charges and expenses include stock-based compensation related to stock options, restricted stock and employee stock purchases made under our employee stock purchase plan, purchase accounting amortization, accelerated depreciation, and early lease termination charges, all net of the associated tax impact, tax benefits from the release of tax reserves, transfer pricing, tax deduction and tax credit adjustments, and the impact of tax law changes. We exclude these expenses from our non-GAAP measures primarily because Plantronics' management does not believe they are part of our target operating model. We believe that the use of non-GAAP financial measures provides meaningful supplemental information regarding our performance and liquidity and helps investors compare actual results with our long-term target operating model goals. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods; however, non-GAAP financial measures are not meant to be considered in isolation or as a substitute for, or superior to, gross margin, operating income, operating margin, net income or EPS prepared in accordance with GAAP.

 
Summary of Unaudited Reconciliations of GAAP Measures to Non-GAAP Measures and other Unaudited GAAP Data
($ in thousands, except per share data)           
    Q116   Q216   Q316   Q416   Q117
GAAP Gross profit   $ 107,358     $ 110,970     $ 109,516     $ 106,830     $ 113,073  
  Stock-based compensation     779       879       811       837       842  
Non-GAAP Gross profit   $ 108,137     $ 111,849     $ 110,327     $ 107,667     $ 113,915  
Non-GAAP Gross profit %     52.4 %     52.0 %     48.9 %     51.3 %     51.1 %
                                         
GAAP Operating expenses   $ 77,996     $ 76,874     $ 82,868     $ 88,895     $ 81,822  
  Stock-based compensation     (7,271 )     (7,953 )     (6,906 )     (7,829 )     (7,571 )
  Purchase accounting amortization     (62 )     (63 )     (62 )     (63 )     (62 )
  Restructuring and other related charges     -       -       (8,433 )     (7,727 )     1,048  
Non-GAAP Operating expenses   $ 70,663     $ 68,858     $ 67,467     $ 73,276     $ 75,237  
                                         
GAAP Operating income   $ 29,362     $ 34,096     $ 26,648     $ 17,935     $ 31,251  
  Stock-based compensation     8,050       8,832       7,717       8,666       8,413  
  Purchase accounting amortization     62       63       62       63       62  
  Restructuring and other related charges     -       -       8,433       7,727       (1,048 )
Non-GAAP Operating income   $ 37,474     $ 42,991     $ 42,860     $ 34,391     $ 38,678  
Non-GAAP Operating income %     18.2 %     20.0 %     19.0 %     16.4 %     17.3 %
                                         
GAAP Income before income taxes   $ 26,336     $ 24,638     $ 19,829     $ 11,373     $ 26,315  
  Stock-based compensation     8,050       8,832       7,717       8,666       8,413  
  Purchase accounting amortization     62       63       62       63       62  
  Restructuring and other related charges     -       -       8,433       7,727       (1,048 )
Non-GAAP Income before income taxes   $ 34,448     $ 33,533     $ 36,041     $ 27,829     $ 33,742  
                                         
GAAP Income tax expense   $ 5,108     $ 6,742     $ 3,541     $ (1,607 )   $ 5,928  
  Income tax effect of above items     2,338       2,656       3,549       6,004       2,753  
  Income tax effect of unusual tax items     994       177       1,419       2,386       86  
Non-GAAP Income tax expense   $ 8,440     $ 9,575     $ 8,509     $ 6,783     $ 8,767  
Non-GAAP Income tax expense as a % of Non-GAAP Income before income taxes     24.5 %     28.6 %     23.6 %     24.4 %     26.0 %
   
   
Summary of Unaudited Reconciliations of GAAP Measures to Non-GAAP Measures and other Unaudited GAAP Data (Continued)  
($ in thousands, except per share data)                
    Q116     Q216     Q316     Q416     Q117  
GAAP Net income   $ 21,228     $ 17,896     $ 16,288     $ 12,980     $ 20,387  
  Stock-based compensation     8,050       8,832       7,717       8,666       8,413  
  Purchase accounting amortization     62       63       62       63       62  
  Restructuring and other related charges     -       -       8,433       7,727       (1,048 )
  Income tax effect of above items     (2,338 )     (2,656 )     (3,549 )     (6,004 )     (2,753 )
  Income tax effect of unusual tax items     (994 )     (177 )     (1,419 )     (2,386 )     (86 )
Non-GAAP Net income   $ 26,008     $ 23,958     $ 27,532     $ 21,046     $ 24,975  
                                         
GAAP Diluted earnings per common share   $ 0.55     $ 0.52     $ 0.49     $ 0.39     $ 0.62  
  Stock-based compensation     0.21       0.26       0.24       0.26       0.26  
  Restructuring and other related charges     -       -       0.25       0.23       (0.03 )
  Income tax effect     (0.09 )     (0.08 )     (0.15 )     (0.24 )     (0.09 )
Non-GAAP Diluted earnings per common share   $ 0.67     $ 0.70     $ 0.83     $ 0.64     $ 0.76  
                                         
Shares used in diluted earnings per common share calculation     38,943       34,245       33,259       33,038       32,818  
 
 
SUMMARY OF UNAUDITED GAAP DATA           
($ in thousands)           
Net revenues from unaffiliated customers:                              
  Enterprise   $ 151,757   $ 160,468   $ 158,251   $ 156,190   $ 155,897
  Consumer     54,601     54,549     67,484     53,607     67,209
    Total net revenues   $ 206,358   $ 215,017   $ 225,735   $ 209,797   $ 223,106
Net revenues by geographic area from unaffiliated customers:                              
  Domestic   $ 117,578   $ 123,803   $ 122,075   $ 119,166   $ 128,238
  International     88,780     91,214     103,660     90,631     94,868
    Total net revenues   $ 206,358   $ 215,017   $ 225,735   $ 209,797   $ 223,106
                               
                               
Balance Sheet accounts and metrics:                              
Accounts receivable, net   $ 127,160   $ 139,939   $ 136,402   $ 128,219   $ 133,155
Days sales outstanding (DSO)     55     59     54     59     54
Inventory, net   $ 55,918   $ 57,760   $ 55,650   $ 53,162   $ 53,912
Inventory turns     7.1     7.2     8.3     7.7     8.2

Image Available: http://www.marketwire.com/library/MwGo/2016/8...a0e8e1.jpg

INVESTOR CONTACT: Greg Klaben Vice President of Investor Relations (831) 458-7533 MEDIA CONTACT: George Gutierrez Sr. Director, Global Communications & Content Strategy (831) 458-7537

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 180

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 298

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 343

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 229

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading